Skip to main content
Equibles

Decheng Capital LLC

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 2010850 MENLO PARK, CA
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,418,135
+$3,321,550 QoQ
Shares Held
1,323,327
0.0% QoQ
Ownership
1.85%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#11
of 114 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Decheng Capital LLC holds $731,749,065 across 14 Biotechnology names. ZNTL ranks #11 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 6,371,669 $452,707,082
2 NUVB
Nuvation Bio Inc.
 25,954,439 $147,421,213
3 AARD
Aardvark Therapeutics, Inc.
 3,917,299 $22,563,642
4 ACRS
Aclaris Therapeutics, Inc.
 4,041,736 $21,380,783
5 UPB
Upstream Bio, Inc.
 2,724,868 $18,856,086
6 RCUS
Arcus Biosciences, Inc.
 464,779 $14,329,136
7 EQ
Equillium, Inc.
 4,447,308 $14,231,385
8 RVMD
Revolution Medicines, Inc.
 52,667 $9,863,475

All Filings in ZNTL

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,418,135 1,323,327
2026-03-31 $3,096,585 1,323,327
2025-12-31 $1,786,491 1,323,327
2025-09-30 $1,998,223 1,323,327
2025-06-30 $1,535,059 1,323,327
2025-03-31 $3,211,421 2,019,762
2024-12-31 $7,084,427 2,338,095
2024-09-30 $11,437,789 3,108,095
2024-06-30 $12,558,107 3,070,442
2024-03-31 $33,089,428 2,099,583
2023-12-31 $31,808,682 2,099,583